UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extensive phosphorylation with overlapping specificity by Mycobacterium tuberculosis serine/threonine protein kinases

Proceedings of the National Academy of Sciences - PNAS, 2010-04, Vol.107 (16), p.7521-7526

2010

Volltextzugriff (PDF)

The Properties of Known Drugs. 1. Molecular Frameworks

Journal of medicinal chemistry, 1996-07, Vol.39 (15), p.2887-2893

1996

Volltextzugriff (PDF)

BREED: Generating Novel Inhibitors through Hybridization of Known Ligands. Application to CDK2, P38, and HIV Protease

Journal of medicinal chemistry, 2004-05, Vol.47 (11), p.2768-2775

2004

Volltextzugriff (PDF)

Structure-Guided Design of Potent and Selective Pyrimidylpyrrole Inhibitors of Extracellular Signal-Regulated Kinase (ERK) Using Conformational Control

Journal of medicinal chemistry, 2009-10, Vol.52 (20), p.6362-6368

2009

Volltextzugriff (PDF)

Properties of Known Drugs. 2. Side Chains

Journal of medicinal chemistry, 1999-12, Vol.42 (25), p.5095-5099

1999

Volltextzugriff (PDF)

Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase

Bioorganic & medicinal chemistry letters, 2009-06, Vol.19 (11), p.3019-3022

2009

Volltextzugriff (PDF)

Designing Libraries with CNS Activity

Journal of medicinal chemistry, 1999-12, Vol.42 (24), p.4942-4951

1999

Volltextzugriff (PDF)

Flipped Out: Structure-Guided Design of Selective Pyrazolylpyrrole ERK Inhibitors

Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1280-1287

2007

Volltextzugriff (PDF)

Kinase inhibitors and the case for CH…O hydrogen bonds in protein–ligand binding

Proteins, structure, function, and bioinformatics, 2002-12, Vol.49 (4), p.567-576

2002

Volltextzugriff (PDF)

The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor

ACS medicinal chemistry letters, 2011-10, Vol.2 (10), p.758-763

2011

Volltextzugriff (PDF)

A minimalist approach to fragment-based ligand design using common rings and linkers: Application to kinase inhibitors

Proteins, structure, function, and bioinformatics, 2004-10, Vol.57 (1), p.36-50

2004

Volltextzugriff (PDF)

CORES: An Automated Method for Generating Three-Dimensional Models of Protein/Ligand Complexes

Journal of medicinal chemistry, 2004-09, Vol.47 (19), p.4731-4740

2004

Volltextzugriff (PDF)

Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions

ACS medicinal chemistry letters, 2017-12, Vol.8 (12), p.1224-1229

2017

Volltextzugriff (PDF)

Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding

Proteins, structure, function, and bioinformatics, 2002-12, Vol.49 (4), p.567-576

2002

Volltextzugriff (PDF)

Structure-based design and parallel synthesis of N-benzyl isatin oximes as JNK3 MAP kinase inhibitors

Bioorganic & medicinal chemistry letters, 2009-05, Vol.19 (10), p.2891-2895

2009

Volltextzugriff (PDF)

The SHAPES strategy: an NMR-based approach for lead generation in drug discovery

Chemistry & biology, 1999-10, Vol.6 (10), p.755-769

1999

Volltextzugriff (PDF)

Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)

Bioorganic & medicinal chemistry, 2008-12, Vol.18 (23), p.6231-6235

2008

Volltextzugriff (PDF)

4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and selective p70S6 kinase inhibitors

Bioorganic & medicinal chemistry letters, 2009-09, Vol.19 (17), p.5191-5194

2009

Volltextzugriff (PDF)

Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases

Current medicinal chemistry, 1999-09, Vol.6 (9), p.807-823

1999

Volltextzugriff (PDF)

A molecular dynamics study of the stability of chymotrypsin acyl enzymes

Journal of the American Chemical Society, 1992-01, Vol.114 (2), p.570-578

1992

Volltextzugriff (PDF)

Dramatic reversal of diastereoselectivity in an N-acyliminium ion cyclization leading to hexahydropyrrolo[2,1-a]isoquinolines. A case of competing steric interactions

Journal of organic chemistry, 1986-04, Vol.51 (8), p.1341-1346

1986

Volltextzugriff (PDF)

Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro

Biochemical journal, 1996-12, Vol.320 ( Pt 2) (2), p.681-686

1996

Volltextzugriff (PDF)

The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase

Chemistry & biology, 1997-06, Vol.4 (6), p.423-431

1997

Volltextzugriff (PDF)

A fast and efficient method for 2D and 3D molecular shape description

Journal of computer-aided molecular design, 1992-12, Vol.6 (6), p.607-628

1992

Volltextzugriff (PDF)

Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1β converting enzyme

Bioorganic & medicinal chemistry letters, 1997-09, Vol.7 (17), p.2181-2186

1997

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)
Dissertationen
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Extensive phosphorylation with overlapping specificity by Mycobacterium tuberculosis serine/threonine protein kinases

The Properties of Known Drugs. 1. Molecular Frameworks

BREED: Generating Novel Inhibitors through Hybridization of Known Ligands. Application to CDK2, P38, and HIV Protease

Structure-Guided Design of Potent and Selective Pyrimidylpyrrole Inhibitors of Extracellular Signal-Regulated Kinase (ERK) Using Conformational Control

Properties of Known Drugs. 2. Side Chains

Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase

Designing Libraries with CNS Activity

Flipped Out: Structure-Guided Design of Selective Pyrazolylpyrrole ERK Inhibitors

Kinase inhibitors and the case for CH…O hydrogen bonds in protein–ligand binding

The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor

A minimalist approach to fragment-based ligand design using common rings and linkers: Application to kinase inhibitors

CORES: An Automated Method for Generating Three-Dimensional Models of Protein/Ligand Complexes

Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions

Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding

Structure-based design and parallel synthesis of N-benzyl isatin oximes as JNK3 MAP kinase inhibitors

The SHAPES strategy: an NMR-based approach for lead generation in drug discovery

Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)

4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and selective p70S6 kinase inhibitors

Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases

A molecular dynamics study of the stability of chymotrypsin acyl enzymes

Dramatic reversal of diastereoselectivity in an N-acyliminium ion cyclization leading to hexahydropyrrolo[2,1-a]isoquinolines. A case of competing steric interactions

Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro

The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase

A fast and efficient method for 2D and 3D molecular shape description

Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1β converting enzyme

Suchergebnisse filtern